Compound ID | 2060
Class: Antibacterial sulfonamide (sulfa drug)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Sulphonamides are structural analogues of p-aminobenzoic acid and act as competitive inhibitors (and alternate substrates) of dihydropteroate synthase (DHPS) to block the synthesis of folic acid. Primarily bacteriostatic; rapid emergence of resistance. |
Description: | Synthetic sufanilamide derivative. Various topical and ophthalmic preparations. |
Year first mentioned: | 1941 |
Development status: | Approved, off-patent |
Chemical structure(s): | |
Canonical SMILES: | CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N |
Isomeric SMILES: | CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N |
InChI: | InChI=1S/C8H10N2O3S/c1-6(11)10-14(12,13)8-4-2-7(9)3-5-8/h2-5H,9H2,1H3,(H,10,11) |
InChI Key: | SKIVFJLNDNKQPD-UHFFFAOYSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/5320 |
External links: | |
Guide to Pharmacology: | sulfacetamide |
Main Source: | https://pubmed.ncbi.nlm.nih.gov/13476879/ |